LI
PTLA

LMCG Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

LMCG Investments’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$364K Buy
8,549
+755
+10% +$36.4K 0.01% 495
2015
Q2 		$355K Buy
+7,794
New +$314K 0.01% 492

Other funds holding PTLA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LMCG Investments's PTLA Position: Q3 2015 in Review

LMCG Investments increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 9.7% in Q3 2015, buying an estimated $36.4K and bringing the position to 8,549 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #495.

LMCG Investments first reported a position in PTLA in Q2 2015 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold PTLA as of Q3 2015.

  • LMCG Investments held 8,549 shares of Portola Pharmaceuticals, Inc. worth $364K as of Q3 2015.
  • LMCG Investments bought 755 Portola Pharmaceuticals, Inc. shares in Q3 2015, an estimated $36.4K.
  • Portola Pharmaceuticals, Inc. made up 0.01% of LMCG Investments's portfolio in Q3 2015, its #495 holding.
  • LMCG Investments first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.